Dr Lal PathLabs Ltd. has approved the acquisition of a 70% stake in SN Genelab Private Ltd. for a cash consideration of up to Rs.168 crore. The transaction also includes a performance-linked earn-out of up to Rs.31.5 crore, subject to the agreed conditions.
The acquisition will expand Dr Lal PathLabs’ presence in specialised diagnostic services. The company will acquire the majority stake in SN Genelab, while the transaction is expected to add to its diagnostic network and capabilities after completion of the applicable processes.
